Michael Matson
Stock Analyst at Needham
(4.45)
# 1,169
Out of 5,090 analysts
1618
Total ratings
51.7%
Success rate
7.4%
Average return
Main Sectors:
Stocks Rated by Michael Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MMSI Merit Medical Systems | Reiterated: Buy | $101 → $106 | $86.24 | +22.91% | 71 | Oct 30, 2026 | |
| RMD ResMed | Reiterated: Hold | n/a | $229.94 | - | 97 | Oct 30, 2026 | |
| SYK Stryker | Reiterated: Buy | $418 → $359 | $291.86 | +23.00% | 76 | Oct 30, 2026 | |
| CNMD CONMED | Reiterated: Hold | n/a | $44.29 | - | 84 | Oct 29, 2026 | |
| NEO NeoGenomics | Reiterated: Buy | $22 | $17.38 | +26.58% | 41 | Oct 29, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $57 → $48 | $41.98 | +14.34% | 129 | Oct 28, 2026 | |
| HAE Haemonetics | Reiterated: Hold | n/a | $119.65 | - | 49 | Oct 21, 2026 | |
| ESTA Establishment Labs Holdings | Reiterated: Buy | $95 | $62.46 | +52.10% | 12 | Oct 15, 2026 | |
| ENOV Enovis | Reiterated: Buy | $52 → $34 | $19.91 | +70.77% | 20 | Oct 12, 2026 | |
| INGN Inogen | Reiterated: Buy | $12 | $6.86 | +74.93% | 88 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.4048 | +641.11% | 34 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $106 | $65.99 | +60.63% | 31 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $114 | $96.54 | +18.09% | 100 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $69 | $50.01 | +37.97% | 37 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $64 | $61.25 | +4.49% | 104 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $159 → $170 | $139.77 | +21.63% | 72 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $2.96 | +204.05% | 37 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $58 | $52.24 | +11.03% | 1 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $22.58 | +94.86% | 61 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $165 → $187 | $163.78 | +14.18% | 14 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $15.82 | - | 40 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $227.12 | - | 34 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $13.22 | - | 42 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $35 | $30.87 | +13.38% | 52 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $81 → $93 | $78.97 | +17.77% | 87 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $94.52 | - | 89 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $318.95 | - | 24 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.025 | n/a | 2 | Apr 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $82 | $78.05 | n/a | 22 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $21.23 | n/a | 1 | Mar 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.88 | n/a | 50 | Dec 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.70 | n/a | 10 | Nov 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 | $11.41 | n/a | 1 | Nov 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $636 | $432.01 | n/a | 1 | Apr 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $15 → $14 | $7.49 | n/a | 4 | Apr 9, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $9.07 | n/a | 1 | Apr 17, 2009 |
Merit Medical Systems
Oct 30, 2026
Reiterated: Buy
Price Target: $101 → $106
Current: $86.24
Upside: +22.91%
ResMed
Oct 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $229.94
Upside: -
Stryker
Oct 30, 2026
Reiterated: Buy
Price Target: $418 → $359
Current: $291.86
Upside: +23.00%
CONMED
Oct 29, 2026
Reiterated: Hold
Price Target: n/a
Current: $44.29
Upside: -
NeoGenomics
Oct 29, 2026
Reiterated: Buy
Price Target: $22
Current: $17.38
Upside: +26.58%
Boston Scientific
Oct 28, 2026
Reiterated: Buy
Price Target: $57 → $48
Current: $41.98
Upside: +14.34%
Haemonetics
Oct 21, 2026
Reiterated: Hold
Price Target: n/a
Current: $119.65
Upside: -
Establishment Labs Holdings
Oct 15, 2026
Reiterated: Buy
Price Target: $95
Current: $62.46
Upside: +52.10%
Enovis
Oct 12, 2026
Reiterated: Buy
Price Target: $52 → $34
Current: $19.91
Upside: +70.77%
Inogen
Oct 1, 2026
Reiterated: Buy
Price Target: $12
Current: $6.86
Upside: +74.93%
Oct 1, 2026
Reiterated: Buy
Price Target: $3
Current: $0.4048
Upside: +641.11%
Sep 22, 2026
Rated: Buy
Price Target: $106
Current: $65.99
Upside: +60.63%
Sep 17, 2026
Reiterated: Buy
Price Target: $114
Current: $96.54
Upside: +18.09%
Sep 15, 2026
Reiterated: Buy
Price Target: $69
Current: $50.01
Upside: +37.97%
Sep 2, 2026
Reiterated: Buy
Price Target: $45 → $64
Current: $61.25
Upside: +4.49%
Aug 25, 2026
Rated: Buy
Price Target: $159 → $170
Current: $139.77
Upside: +21.63%
Aug 18, 2026
Reiterated: Buy
Price Target: $9
Current: $2.96
Upside: +204.05%
Aug 17, 2026
Initiated Coverage: Buy
Price Target: $58
Current: $52.24
Upside: +11.03%
Aug 7, 2026
Reiterated: Buy
Price Target: $44
Current: $22.58
Upside: +94.86%
Aug 7, 2026
Rated: Buy
Price Target: $165 → $187
Current: $163.78
Upside: +14.18%
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $15.82
Upside: -
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $227.12
Upside: -
Aug 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $13.22
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: $30 → $35
Current: $30.87
Upside: +13.38%
Aug 5, 2026
Reiterated: Buy
Price Target: $81 → $93
Current: $78.97
Upside: +17.77%
Aug 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $94.52
Upside: -
Feb 25, 2026
Reiterated: Hold
Price Target: n/a
Current: $318.95
Upside: -
Apr 5, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.025
Upside: n/a
May 5, 2021
Reiterated: Buy
Price Target: $65 → $82
Current: $78.05
Upside: n/a
Mar 18, 2020
Reiterated: Buy
Price Target: $27
Current: $21.23
Upside: n/a
Dec 6, 2018
Rated: Hold
Price Target: n/a
Current: $3.88
Upside: n/a
Nov 11, 2016
Reiterated: Buy
Price Target: n/a
Current: $1.70
Upside: n/a
Nov 6, 2015
Reiterated: Buy
Price Target: $1
Current: $11.41
Upside: n/a
Apr 19, 2013
Reiterated: Buy
Price Target: $636
Current: $432.01
Upside: n/a
Apr 9, 2013
Upgraded: Buy
Price Target: $15 → $14
Current: $7.49
Upside: n/a
Apr 17, 2009
Downgraded: Sell
Price Target: n/a
Current: $9.07
Upside: n/a